Apriso ER 0.375 gram capsule 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F18QQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,375
Award facts
- Contract value 100% obligated
- $10,375.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on November 25, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of Apriso ER 0.375 gram capsules (120-count) with a contract ceiling value of $10,375.24. The award is structured as a firm fixed-price delivery order with no set-aside designation, indicating open competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of November 26, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement extending through December 2026 that authorizes the company to supply pharmaceuticals and medical supplies to support military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, continues to serve as a critical federal medical procurement vendor through this competitive award. The company's extensive contract portfolio with the DLA demonstrates its capability to fulfill diverse federal medical supply requirements across multiple therapeutic domains. This award reflects the ongoing reliance on AmerisourceBergen as a primary pharmaceutical supplier for military and veteran healthcare systems, supporting the DLA's broader mission to supply medical commodities to defense and civilian healthcare entities within the federal government.
Quick answers
Who was awarded contract SPE2DR26F18QQ?
SPE2DR26F18QQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F18QQ worth?
The government has obligated $10,375 on SPE2DR26F18QQ.
Is contract SPE2DR26F18QQ an order under another contract?
Yes. SPE2DR26F18QQ is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F18QQ competed?
The extent of competition for SPE2DR26F18QQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award